<DOC>
	<DOCNO>NCT02328742</DOCNO>
	<brief_summary>The main objective study describe level expression biological factor involve formation adhesion ( Transforming growth factor beta , Activin A , inhibin ) time first diagnostic hysteroscopy among woman synechia , another intracavitary disease intracavitary disease .</brief_summary>
	<brief_title>Development Bioabsorbable Medical Device Prevention Postoperative Intra-uterine Adhesions .</brief_title>
	<detailed_description>The secondary obectives : A . For woman find synechia another intracavitary pathology time resection : To describe level Transforming growth factor beta , Activin A Inhibin involve synechia time resection . B . For woman find synechia another intracavitary pathology time resection : To describe level Transforming growth factor beta , Activin A Inhibin involve synechia time follow-up hysteroscopy follow resection . C. For woman find synechia time resection : To describe change level Transforming growth factor beta , Activin A Inhibin involved time follow-up hysteroscopy follow resection whether patient convert back `` synechia '' . D. For woman find another intracavitary pathology time resection : To describe change level Transforming growth factor beta , Activin A Inhibin involved time follow-up hysteroscopy follow resection whether patient convert `` synechia '' . E. To estimate intra-individual variation measure factor ( initial biopsy level versus level time resection ) . F. To create intrauterine map factor level accord biopy position ( riosteal / medium / proximal ) patient synechia another intracavitary pathology time resection follow-up hysteroscopy . G. To describe level Transforming growth factor beta , Activin A Inhibin function pregnancy 6 month resection . H. Create tissue bank associate study .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<criteria>The patient must give free informed consent must sign consent form The patient must affiliate beneficiary health insurance plan Indication hysteroscopy associate one following : infertility evaluation , postoperative dysmenorrhea , embryo implantation failure invitro fertilization , recurrent miscarriages The patient participate another study The patient exclusion period determine previous study The patient judicial protection , guardianship curatorship The patient refuse sign consent It possible correctly inform patient The patient postmenopausal Indication hysteroscopy associate exploration infertility dysmenorrhea Presence endometritis objectify via sample diagnostic hysteroscopy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>